⌘K

Login Start Free

Home/Filings/4/0001991925-23-000002

4//SEC Filing

Symetryx Corp 4

Accession 0001991925-23-000002

CIK 0001173281other

View on SEC.gov Company Profile

Filed

Sep 6, 8:00 PM ET

Accepted

Sep 7, 5:19 PM ET

Size

4.8 KB

Accession

0001991925-23-000002

Insider Transaction Report

Form 4

Period: 2023-09-01

NeuBase Therapeutics, Inc.NBSE

10% Owner

Transactions

Purchase
Common Stock, Par Value $0.0001 per Share
2023-09-01$0.98/sh+61,076$59,732→ 680,081 total

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

NeuBase Therapeutics, Inc.

CIK 0001173281

Entity typeother

IncorporatedOntario, Canada

Related Parties

1

filerCIK 0001991925

Filing Metadata

Form type: 4
Filed: Sep 6, 8:00 PM ET
Accepted: Sep 7, 5:19 PM ET
Size: 4.8 KB

View on SEC.gov